ClearPoint Neuro (CLPT) Income towards Parent Company (2011 - 2026)
ClearPoint Neuro (CLPT) reported Income towards Parent Company of -$9.6 million for Q1 2026, down 58.51% on a YoY basis from -$23.0 million in Q1 2025, and down 23.2% sequentially from -$7.8 million in Q4 2025.
ClearPoint Neuro (CLPT) Income towards Parent Company (2011 - 2026) Analysis & Trends
ClearPoint Neuro (CLPT) has 15 years of Income towards Parent Company data on file, last reported at -$9.6 million in Q1 2026.
- For the quarter ending Q1 2026, Income towards Parent Company fell 58.51% year-over-year to -$9.6 million; the trailing twelve-month figure through Mar 2026 stood at -$29.0 million (down 44.21% YoY), and the FY2025 full-year result was -$25.5 million, down 39.75% from the prior year.
- Income towards Parent Company declined to -$9.6 million in Q1 2026, from -$7.8 million in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of -$4.1 million in Q1 2024 to a low of -$14.7 million in Q2 2022.
- A 5-year average of -$7.6 million and a median of -$6.0 million in 2025 frame the typical range for Income towards Parent Company.
- Across the five-year window, Income towards Parent Company surged 62.47% in 2024 and slumped 64.12% in 2025, its largest moves.
- Tracing CLPT's Income towards Parent Company over 5 years: stood at -$4.6 million in 2022, then retreated by 5.47% to -$4.9 million in 2023, then increased by 3.49% to -$4.7 million in 2024, then plunged by 64.12% to -$7.8 million in 2025, then fell by 23.2% to -$9.6 million in 2026.
- Business Quant data shows CLPT's Income towards Parent Company at -$9.6 million in Q1 2026, -$7.8 million in Q4 2025, and -$5.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | ClearPoint Neuro | 431.98 Mn | 396.38 Mn | 7.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.55 Mn |
| Dec 31, 2025 | -7.75 Mn |
| Sep 30, 2025 | -5.89 Mn |
| Jun 30, 2025 | -5.84 Mn |
| Mar 31, 2025 | -6.03 Mn |
| Dec 31, 2024 | -4.72 Mn |
| Sep 30, 2024 | -4.97 Mn |
| Jun 30, 2024 | -4.41 Mn |
| Mar 31, 2024 | -4.15 Mn |
| Dec 31, 2023 | -4.90 Mn |
| Sep 30, 2023 | -6.76 Mn |
| Jun 30, 2023 | -11.23 Mn |
| Mar 31, 2023 | -11.05 Mn |
| Dec 31, 2022 | -4.64 Mn |
| Sep 30, 2022 | -11.05 Mn |
| Jun 30, 2022 | -14.68 Mn |
| Mar 31, 2022 | -11.36 Mn |
| Dec 31, 2021 | -4.08 Mn |
| Sep 30, 2021 | -19.13 Mn |
| Jun 30, 2021 | -18.32 Mn |